| Description | This antibody is a human neutralizing antibody clone S8V2-18 binding with IAV HA (Influenza A Virus hemagglutinin). It is a broadly protective antibody against Influenza Virus hemagglutinin. It recognizes a conserved region at the influenza A virus HA head interface. This product has been detected using Enzyme-linked immunosorbent assay, Bio-layer interferometry and Neutralization assay. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | IAV |
| Epitope | A conserved region at the influenza virus hemagglutinin (HA) head (the globular, receptor-binding domains at the apex of the spike-like trimer) interface. |
| Isotype | Human IgG |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; BLI; Neut |
| Application Notes | This antibody has been evaluated by ELISA and Bio-layer interferometry (BLI). ELISA: 5-fold dilutions of IgG (in PBS-T) was incubated for 1 h at room temperature. Bio-layer interferometry (BLI): Purified His-tagged antibody was immobilized on a Ni-NTA biosensor. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | IAV HA |
| Alternative Name | Hemagglutinin |
| Research Area | Infectious Disease |
| Related Disease | Influenza |
